Saturday, January 10, 2015 11:45:46 AM
We are here talking and reading about HyperSolar more frequently now than we would like. Mostly from excitement! We are all here because we understand the implicit results which will come from HyperSolar's H2Generator, and associated family of products - as well as their future products.
First matter of business - Understanding our equal aspirations
We all hope HYSR succeeds. We all want to see maturity of our investment.
HyperSolar is an "American company" with global implications.
To invest in an American company and have the stock price "bouncing" such as it does, makes you question American securities all together. Many investors are not happy to have purchased interest in the company and feel that Americans are manipulating prices. I have come to understand, that this is a concern.
With HyperSolar's Low Trading Volume - It is true that any truly "Rich" person could buy and sell ALL HYSR stock and sell it 100x over. In the stock market - it is true that stocks go under such "Short Attacks" all day every day. Many stocks have 50-75% of shares lended out to Short Sellers via Borkerage Firms.
This can be prevented with HYSR as we transition every single share to private holders.
Presently we have no way to account for how many shares we as individuals own.
We must create a spreadsheet that documents our country of nationality, and register our shares.
In columns we can also suggest each other notes on holdings.
Remember we can only be under Short Attack while so many shares are in hands of corporate financiers instead of Investors.
I believe it is possible we have been under Short Attack since the initial 0.13 pop.
You should all know what I am discussing.
Why would it pop to $0.13 and then dissipate to $0.01?
We have two leading American universities who have become experts on some aspects of the refinement process thru their various studies. It is very possible that HYSR eventually opens up patents to all who wish to produce such devices. They may also be licensing patents from other international research teams who improve upon the architecture.
Thru my research I have come to see international investors disgruntled at share price volatility.
I believe the goal of the Short Attack is to push HYSR in to further financing.
At their present stage of development - The SHARE PRICE will reflect their financing rates.
Let's collaborate and move in lockstep so we can move things forward.
I am excited for Monday morning! I purchased almost 700,000 shares on Friday after seeing no room to buy below $0.02
Let's continue this dialogue I would really appreciate thoughts and responses.
We must create dialogue amongst ourselves as share holders.
Recent HYSR News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 08:06:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:05:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/21/2024 07:32:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM